Traditional Thai Medical Research and Innovation Center, Faculty of Traditional Thai Medicine, Prince of Songkla University, Songkhla, Thailand.
Division of Biological Science, Faculty of Science, Prince of Songkla University, Songkhla, Thailand.
Pharm Biol. 2024 Dec;62(1):648-658. doi: 10.1080/13880209.2024.2385456. Epub 2024 Aug 16.
Craib. and L., of the Fabaceae, have been used as active components in Thai herbal formulas for the treatment of fever and skin diseases.
To evaluate the physicochemical and pharmacological properties of the developed herbal gel formulation containing the combined extract from stem wood and (RGF).
The potential of the herbal gel formulation containing RGF (8% w/w) as the active ingredient was studied by evaluating the anti-inflammatory, antioxidant, and anti- activities using quantitative reverse transcription-polymerase chain reaction assay, spectrophotometric method, and broth microdilution technique, respectively. The reference standards for the biological testing included Nω-nitro-L-arginine (L-NA), ascorbic acid, catechin, and penicillin G. The stability study of the RGF herbal gel was performed by a heating-cooling test (at 45 °C for 24 h and at 4 °C for 24 h/1 cycle; for 6 cycles), and the bioactive marker compounds in the herbal gel were investigated by the HPLC technique.
RGF showed promising pharmacological effects, particularly on its anti-inflammatory property (IC 73.86 µg/mL), compared to L-NA (IC 47.10 µg/mL). The RGF-containing gel demonstrated anti-inflammatory (IC 3.59 mg/mL) and free radical scavenging effects (IC 0.05-4.39 mg/mL), whereas it had no anti- activity (MIC > 10 mg/mL). The active ingredient in the developed herbal gel significantly inhibited lipopolysaccharide-induced nitric oxide production by downregulating iNOS mRNA levels. The contents of the bioactive markers in the RGF gel (lupinifolin and glabridin) did not change significantly after stability testing.
The RGF-containing gel has potential to be further developed as an herbal product for the treatment of skin inflammation.
来自豆科植物的和已被用作泰草药配方中治疗发热和皮肤病的活性成分。
评估含有组合提取物的草药凝胶制剂的理化和药理学性质。
通过使用定量逆转录聚合酶链反应测定法、分光光度法和肉汤微量稀释技术分别评估抗炎、抗氧化和抗活性,研究含有 RGF(8%w/w)的草药凝胶制剂的潜力。生物测试的参考标准包括 Nω-硝基-L-精氨酸(L-NA)、抗坏血酸、儿茶素和青霉素 G。通过加热-冷却试验(在 45°C 下 24 小时和在 4°C 下 24 小时/1 个循环;6 个循环)进行 RGF 草药凝胶的稳定性研究,并通过 HPLC 技术研究草药凝胶中的生物活性标志物化合物。
与 L-NA(IC 47.10μg/mL)相比,RGF 表现出有希望的药理作用,特别是在抗炎作用(IC 73.86μg/mL)方面。含 RGF 的凝胶表现出抗炎(IC 3.59mg/mL)和自由基清除作用(IC 0.05-4.39mg/mL),而没有抗活性(MIC>10mg/mL)。开发的草药凝胶中的活性成分通过下调 iNOS mRNA 水平显著抑制脂多糖诱导的一氧化氮产生。在稳定性测试后,RGF 凝胶中的生物活性标志物(羽扇豆醇和甘草素)的含量没有明显变化。
含有 RGF 的凝胶具有进一步开发为治疗皮肤炎症的草药产品的潜力。